https://www.rapamycinpress.com/blog/oncotarget/possible-new-target-breast-cancer-treatment/
Systematic functional perturbations uncover a prognostic genetic network driving human breast cancer
Oncotarget. 2017; 8:20572-20587. https://doi.org/10.18632/oncotarget.16244
Tristan Gallenne1,9, Kenneth N. Ross4,5,*, Nils L. Visser1,*, Salony4,5,*, Christophe J. Desmet1, Ben S. Wittner4,5, Lodewyk F.A. Wessels2,3, Sridhar Ramaswamy4,5,6,7,8 and Daniel S. Peeper1
1 Department of Molecular Oncology, The Netherlands Cancer Institute, Plesmanlaan, CX, Amsterdam, The Netherlands
2 Department of Molecular Carcinogenesis, The Netherlands Cancer Institute, Plesmanlaan, CX, Amsterdam, The Netherlands
3 Faculty of EEMCS Delft University of Technology, Delft, The Netherlands
4 Massachusetts General Hospital Cancer Center, Boston, MA, USA
5 Harvard Medical School, Boston, MA, USA
6 Broad Institute of Harvard & MIT, Cambridge, MA, USA
7 Harvard Stem Cell Institute, Cambridge, MA, USA
8 Harvard-Ludwig Center for Cancer Research, Boston, MA, USA
9 Current address: Merus B.V., Padualaan, CH Utrecht, The Netherlands
* These authors have contributed equally
Correspondence to:
Sridhar Ramaswamy, email: sridhar@mgh.harvard.edu
Daniel S. Peeper, email: d.peeper@nki.nl
Keywords: breast cancer, metastasis, prognosis, tumor biology
Received: December 14, 2016 Accepted: January 28, 2017 Published: March 15, 2017
http://www.oncotarget.com/index.php?journal=oncotarget&page=article&op=view&path[]=16244&path[]=51959
